+34 620 10 75 37info@nanbiosis.com

Posts on Jan 1970

NANBIOSIS Unit 6 Delivers Training on Particle Characterisation Techniques

NANBIOSIS Unit 6 delivered a hands-on training course on particle characterisation techniques, covering DLS, NTA and light scattering.

Barcelona, October 2026 — From 5 to 7 October 2026, José Amable Bernabé delivered a 21-hour training course on Particle Characterisation Techniques in Bellaterra (Barcelona), highlighting the analytical capabilities available through NANBIOSIS Unit 6.

The course was organised by the Deputy General Secretariat for Human Resources in collaboration with the Institute of Materials Science of Barcelona (ICMAB-CSIC). It was aimed at scientific personnel seeking to develop practical knowledge of techniques used to characterise particulate materials, particularly researchers and staff working at ICMAB.

The programme combined theoretical sessions with hands-on training, introducing participants to three key analytical techniques:

  • Dynamic Light Scattering (DLS): particle size distribution and zeta potential measurements.
  • Nanoparticle Tracking Analysis (NTA): particle size distribution, particle concentration measurements and fluorescence-based analysis.
  • Light Scattering (LS): particle size distribution measurements.

Practical sessions provided participants with the opportunity to analyse samples and interpret experimental results using three analytical instruments: the Zetasizer Nano ZS for DLS, the NanoSight NS300 for NTA and the Mastersizer 2000 for light scattering.

Throughout the course, the connection between these analytical services and NANBIOSIS Unit 6 was highlighted, showcasing the infrastructure’s capabilities in particle characterisation and its contribution to supporting research in materials science and nanotechnology.

Through specialised training and access to advanced analytical equipment, NANBIOSIS continues to support the scientific community in developing and applying techniques essential for the characterisation of advanced materials and nanomaterials.

NANBIOSIS Unit 6: Advanced materials for health

The poster highlights the mission of NANBIOSIS Unit 6, located at ICMAB-CSIC and coordinated by Prof. Nora Ventosa. This Unit specializes in the development, characterisation, and scale-up of molecular biomaterials with applications in biomedicine.

Equipped with state-of-the-art facilities and operating under ISO 9001 quality standards, Unit 6 offers advanced technologies such as the DELOS-SUSP method, a compressed-fluid-based process for producing highly controlled micro- and nanostructured materials. Its unique capability to scale processes from laboratory to industrial levels supports both research and technology transfer.

What is NANBIOSIS?

The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).

If you want to collaborate with us, visit our Order Request page.

Leading scientists

The main value of NANBIOSIS is our highly qualified and experienced academic scientists, working in public institutions, renowned universities and other research institutes.

Custom solutions

Designed for either scientific collaboration or the private industry, we adapt our services to your needs, filling the gaps and paving the way towards the next breakthrough.

Cutting-Edge facilities

Publicly funded, with the most advanced equipment, offering a wide variety of services from synthesis of nanoparticles and medical devices, including up to preclinical trials.

Standards of quality

Our services have standards of quality required in the pharmaceutical, biotech and medtech sectors, from Good Practices to ISO certifications.

In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:

• Read More

NANBIOSIS Joins the V Annual Conference of Spain’s Singular Scientific and Technical Infrastructures in Zaragoza

NANBIOSIS took part in the 2026 ICTS Conference in Zaragoza, bringing together Spain’s leading scientific infrastructures to exchange knowledge and explore collaboration opportunities.

Zaragoza, October 2026 — Last 29 October 2026, the V Annual Conference of Spain’s Singular Scientific and Technical Infrastructures (ICTS) took place in Zaragoza, bringing together representatives from across the Spanish ICTS network. The event provided a forum to share developments, strengthen collaboration between infrastructures and showcase their scientific and technological capabilities to the research and industrial communities.

This year’s conference was hosted by the Laboratory of Advanced Microscopy (LMA) and the Institute for Biocomputation and Physics of Complex Systems (BIFI), both at the University of Zaragoza. Sessions were held at the Agustín de Betancourt Building, home to the University’s School of Engineering and Architecture (EINA).

The programme included two round tables addressing key challenges for research infrastructures: artificial intelligence in ICTS and data management plans (DMPs). These discussions provided an opportunity to exchange perspectives on the role of emerging technologies and effective data management in the development and operation of large-scale scientific facilities.

Participants also had the opportunity to visit the LMA facilities and the Aragonese node of the Spanish Supercomputing Network (RES), alongside the conference’s networking activities.

The event scenified a minute of silence in memory of the victims of the Urda train accident. In addition, participants who were unable to attend in person were offered the possibility of joining the sessions by videoconference.

Through its participation, NANBIOSIS reaffirmed its commitment to the Spanish ICTS network, contributing to a shared effort to promote scientific excellence, facilitate access to advanced research infrastructures and foster collaboration across the national research and innovation ecosystem.

What is NANBIOSIS?

The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).

If you want to collaborate with us, visit our Order Request page.

Leading scientists

The main value of NANBIOSIS is our highly qualified and experienced academic scientists, working in public institutions, renowned universities and other research institutes.

Custom solutions

Designed for either scientific collaboration or the private industry, we adapt our services to your needs, filling the gaps and paving the way towards the next breakthrough.

Cutting-Edge facilities

Publicly funded, with the most advanced equipment, offering a wide variety of services from synthesis of nanoparticles and medical devices, including up to preclinical trials.

Standards of quality

Our services have standards of quality required in the pharmaceutical, biotech and medtech sectors, from Good Practices to ISO certifications.

In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:

• Read More

NANBIOSIS Promotes Nanomedicine Through an Educational Game at Science Outreach Events in Barcelona

NANBIOSIS Unit 20 promotes nanomedicine through an interactive educational game presented at several science outreach events in Barcelona.

Barcelona, October 2026 — NANBIOSIS is supporting science communication and public engagement through an educational game developed by its Unit 20 (FVPR), designed to introduce audiences to the fascinating world of nanomedicine and nanoparticle-based technologies.

Entitled “Missió nanoagent: El viatge d’una nanopartícula” (Nano-Agent Mission: The Journey of a Nanoparticle), this boardgame invites participants to explore the journey of a nanoparticle, helping them discover scientific concepts related to nanotechnology and its biomedical applications. The initiative also features the NANBIOSIS logo, raising awareness of the infrastructure and its research capabilities among the general public.

The game has been presented at several science outreach activities in Barcelona, including the Festa de la Ciència at the Centre de Cultura Contemporània de Barcelona (CCB) in April, and the European Researchers’ Night at CosmoCaixa, where it was featured in a session on Friday, 28 September. It was also showcased on 3 October at the Vall d’Hebron Research Institute (VHIR), as part of the 48h Open House Barcelona programme.

NANBIOSIS was also highlighted during the European Researchers’ Night through the talk “¡Hasta el cerebro! La increíble ruta de las nanopartículas” (All the Way to the Brain! The Incredible Journey of Nanoparticles), delivered by Fernanda Andrade at CosmoCaixa. The presentation featured the NANBIOSIS logo and discussed in vivo research results obtained through a service provided by the infrastructure.

Through initiatives like these, NANBIOSIS Units contribute not only to biomedical research and technological development but also to bringing science closer to society, making complex topics such as nanomedicine more accessible and engaging for different audiences.

What is NANBIOSIS?

The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).

If you want to collaborate with us, visit our Order Request page.

Leading scientists

The main value of NANBIOSIS is our highly qualified and experienced academic scientists, working in public institutions, renowned universities and other research institutes.

Custom solutions

Designed for either scientific collaboration or the private industry, we adapt our services to your needs, filling the gaps and paving the way towards the next breakthrough.

Cutting-Edge facilities

Publicly funded, with the most advanced equipment, offering a wide variety of services from synthesis of nanoparticles and medical devices, including up to preclinical trials.

Standards of quality

Our services have standards of quality required in the pharmaceutical, biotech and medtech sectors, from Good Practices to ISO certifications.

In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.

NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:

• Read More